Common Stock SEC Reporting - Current
Verified Company Profile 1/05/2017
Contact Info
  • 4700 Spring Street
  • St 304
  • La Mesa, CA 91942

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001589150
Fiscal Year End 9/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2012
Employees 4 a/o May 23, 2016
Company Officers/Contacts
David Koos CEO
Todd Caven CFO
Dr. Harry M. Lander CSO, President
Company Directors
David Koos Chairman
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel

Not Available
Investor Relations Firm

Not Available
RGBP Security Details Other Company Securities
Share Structure
Market Value1 $5,524,504 a/o Jun 23, 2017
Authorized Shares 500,000,000 a/o Jan 04, 2017
Outstanding Shares 138,112,605 a/o Mar 31, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 82,317,059 a/o Jan 04, 2017
Par Value Not Available
Shareholders of Record 464 a/o Mar 30, 2017
Short Selling Data
Short Interest 2,229 (-82.2%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security